Pharma Stocks
-
Retail Bulls Bet Q3 Obesity Data Could Put Novo, Big Pharma In Buyout Play
Retail traders cited Novo CEO Mike Doustdar’s comment that Novo could afford a $20B, $30B or $40B deal if it…
Read More » -
Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $475.12, marking a +1.43% move from the previous day. The…
Read More » -
Rhythm Pharmaceuticals (RYTM) Is Up 7.9% After Promising Early PWS Data for Setmelanotide – What’s Changed
In June 2026, Rhythm Pharmaceuticals reported preliminary six-month Phase 2 data for setmelanotide in Prader-Willi syndrome, showing improvements in BMI,…
Read More » -
Is Ascletis Pharma (SEHK:1672) Undervalued On FDA Clearance For ASC35?
Ascletis Pharma (SEHK:1672) has attracted investor attention after receiving U.S. FDA Investigational New Drug clearance for ASC35, a once-monthly dual…
Read More » -
Deepened Boston Children’s Partnership Could Be A Game Changer For Nippon Shinyaku (TSE:4516)
Nippon Shinyaku Co., Ltd. has entered into a Sponsored Research Agreement with Boston Children’s Hospital to co-develop innovative neurology drugs,…
Read More » -
Astellas Pharma’s (TSE:4503) Earnings May Just Be The Starting Point
Even though Astellas Pharma Inc.’s (TSE:4503) recent earnings release was robust, the market didn’t seem to notice. Our analysis suggests…
Read More » -
Alnylam Pharmaceuticals, Inc. (ALNY) and GENESIS Pharma Expand Commercial Partnership
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is one of the 12 Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On.…
Read More » -
IT selloff drags Nifty below 24,000; pharma stocks buck the trend
Markets turned sharply lower by midday on Tuesday, with the Nifty 50 slipping below the crucial 24,000 mark after early…
Read More » -
USFDA appeal for critical cancer drugs puts these Indian Pharma shares in focus
Shares of three pharmaceutical companies Cipla Ltd., Alkem Laboratories Ltd. and Zydus Lifesciences Ltd. are in focus on Tuesday, June…
Read More » -
What Signal Does It Send?
Vertex Pharmaceuticals experienced a strong upward movement and significant intraday volatility, driven by a combination of positive institutional data disclosures,…
Read More »